Therapy News and Research

RSS

Vitamin D can reduce severity and spread of COVID-19

In a recent study published in the Scientific Reports journal, researchers in the United States assessed the relationship between supplementation with vitamin D and coronavirus disease 2019 (COVID-19) and related mortality.

15 Nov 2022

Survey: Nearly two-thirds of cancer patients want to know about complementary therapies before treatment

Nearly two-thirds (62%) of people with cancer want to know about complementary therapies such as exercise, nutrition counseling, massage, and meditation before starting conventional treatment, but only 33% of oncologists agree with that timeline, according to a new survey conducted on behalf of Samueli Foundation.

15 Nov 2022

Sanford Burnham Prebys researchers receive ACS grants to advance work on difficult-to-treat cancers

Two faculty members from Sanford Burnham Prebys have been awarded grants from the American Cancer Society (ACS), the largest not-for-profit funding body for scientists studying cancer. Associate Professor Cosimo Commisso, Ph.D., and Assistant Professor Svasti Haricharan, Ph.D., each received competitive awards to advance their work on difficult-to-treat cancers.

15 Nov 2022

Psychologists struggle to meet the increased demand for mental health services

Demand for mental health treatment has continued to increase as many psychologists report no longer having the capacity to see new patients, according to a new survey by the American Psychological Association.

15 Nov 2022

Pancreas transplant more beneficial than other treatments for people with diabetes

Results of pancreas transplantation continue to improve and up to 90% of recipients with diabetes enjoy freedom from both insulin therapy and the need for close glucose monitoring following the procedure, according to a new paper published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

15 Nov 2022

What are the current challenges and future directions of mRNA nanomedicine?

Researchers presented challenges related to the clinical translation of messenger ribonucleic acid (mRNA) technology, recent innovations and future directions to improve the clinical efficacy of mRNA nanomedicine.

15 Nov 2022

Early mobility contributes to higher survival rates for COVID-19 patients receiving ECMO

A Texas cardiac subspecialty hospital with seven years of experience with extracorporeal membrane oxygenation (ECMO) changed its treatment paradigm during the COVID-19 pandemic, finding that progressive mobility and a more aggressive application of rehabilitation therapies contributed to significantly higher survival rates for its patients with COVID-19 receiving ECMO.

15 Nov 2022

Behind the Scenes of the Oncology & Precision Medicine Conferences 2022

During the conference, we caught up with some of the speakers to learn more about their work, what they were presenting, and their thoughts about the future of Oncology and Precision Medicine.

15 Nov 2022

Do SSRIs lower the risk of long COVID?

Researchers conducted a retrospective study to determine whether SSRIs with immunomodulatory and antiplatelet properties can decrease the risk of post-acute sequelae of COVID-19 (PASC).

15 Nov 2022

Short-term outcomes in pregnant patients with COVID-19 who received nirmatrelvir–ritonavir treatment

Researchers investigated the short-term outcomes of treating pregnant patients exhibiting mild to moderate symptoms of COVID-19 with Paxlovid, which is a combination of the antivirals nirmatrelvir and ritonavir.

15 Nov 2022

Prevalence and severity of liver enzyme alterations in COVID-19 and association with patient-centered outcomes

Researchers examined the prevalence of changes in liver enzymes in COVID-19.

15 Nov 2022

Mechanically active adhesive prevents and supports the recovery from muscle atrophy

Muscles waste as a result of not being exercised enough, as happens quickly with a broken limb that has been immobilized in a cast, and more slowly in people reaching an advanced age.

14 Nov 2022

Two simple biomarkers could differentiate which young women with ER+ breast cancer need chemotherapy

New research from Yale Cancer Center identified that two simple biomarkers, immune cells and estrogen receptor levels, could differentiate which young women with ER+ breast cancer need chemotherapy to improve their survival, and which only need a monthly injection to suppress ovarian function.

14 Nov 2022

New discovery reveals which patients will survive longer after receiving immunotherapy

Patients with head and neck cancer who have more genetic material on chromosome 9 in their cancer cells survive three times longer after receiving immunotherapy than those with less genetic material there, a new study finds.

14 Nov 2022

Restorative neurostimulation continues to be effective in treating low-back pain for three years

A study has found that restorative neurostimulation continues to be effective in treating low-back pain caused by multifidus dysfunction after three years.

14 Nov 2022

Exploring antiviral drug combinations for SARS-CoV-2 suppression

Researchers assessed the impact of drug combinations on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) suppression.

14 Nov 2022

Blood samples from healthy individuals have pre-existing anti-SARS-CoV-2 IgGs and IVIg may be an effective therapy for severe COVID-19

A new paper introduces evidence of effective alleviation of disease severity using intravenous immunoglobulin (IVIg).

14 Nov 2022

Test to Treat: geographic disparities in COVID-19 antiviral access

A recent study evaluated the accessibility of COVID-19 ‘Test to Treat’ sites by age, rurality, race, and ethnicity.

14 Nov 2022

First placebo-controlled long-term trial of anifrolumab shows positive results in patients with lupus

Type I interferon (IFN) is a powerful immune activator that is present at high levels in the majority of patients with lupus, an autoimmune disease. In Arthritis & Rheumatology, researchers report positive results from the first placebo-controlled long-term trial of anifrolumab - a human monoclonal antibody that targets the type I IFN receptor - in patients with lupus.

14 Nov 2022

Cancer Research Horizons: The Innovation Engine of Cancer Research UK

Following ELRIG 2022, News-Medical speaks with Cancer Research Horizons, the innovation engine of Cancer Research UK about their efforts to advance the drug discovery sector.

From Cancer Research UK 14 Nov 2022

Therapy News and Research

Vitamin D can reduce severity and spread of COVID-19

Survey: Nearly two-thirds of cancer patients want to know about complementary therapies before treatment

Sanford Burnham Prebys researchers receive ACS grants to advance work on difficult-to-treat cancers

Psychologists struggle to meet the increased demand for mental health services

Pancreas transplant more beneficial than other treatments for people with diabetes

What are the current challenges and future directions of mRNA nanomedicine?

Early mobility contributes to higher survival rates for COVID-19 patients receiving ECMO

Behind the Scenes of the Oncology & Precision Medicine Conferences 2022

Do SSRIs lower the risk of long COVID?

Short-term outcomes in pregnant patients with COVID-19 who received nirmatrelvir–ritonavir treatment

Prevalence and severity of liver enzyme alterations in COVID-19 and association with patient-centered outcomes

Mechanically active adhesive prevents and supports the recovery from muscle atrophy

Two simple biomarkers could differentiate which young women with ER+ breast cancer need chemotherapy

New discovery reveals which patients will survive longer after receiving immunotherapy

Restorative neurostimulation continues to be effective in treating low-back pain for three years

Exploring antiviral drug combinations for SARS-CoV-2 suppression

Blood samples from healthy individuals have pre-existing anti-SARS-CoV-2 IgGs and IVIg may be an effective therapy for severe COVID-19

Test to Treat: geographic disparities in COVID-19 antiviral access

First placebo-controlled long-term trial of anifrolumab shows positive results in patients with lupus

Cancer Research Horizons: The Innovation Engine of Cancer Research UK

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News